BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vujčić I. Outcomes of COVID-19 among patients with liver disease. World J Gastroenterol 2023; 29(5): 815-824 [PMID: 36816621 DOI: 10.3748/wjg.v29.i5.815]
URL: https://www.wjgnet.com/1007-9327/full/v29/i5/815.htm
Number Citing Articles
1
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
2
Fatima Hakak, Rajan N. Patel, Richard B. Gearry. Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyondAlimentary Pharmacology & Therapeutics 2024; 59(10): 1170 doi: 10.1111/apt.17956
3
L. Jiao, D. Bujnowski, P. Liu, E. Bakota, L. Liu, Y. Ye, A. Dewangan, C.N. Duong, E. Kviten, S. Zaheer, A. Zangeneh, R. Roy, J. Floyd, J. Monroy, D. Wiltz-Beckham. Asthma and clinical outcomes of COVID-19 in a community settingPublic Health 2024; 226: 84 doi: 10.1016/j.puhe.2023.10.040
4
Julio Cezar Uili Coelho, Katia Cristina Kampa, Marco Aurelio Raeder da Costa, Daphane Benatti Gonçalves Morsoletto, Diogo Pena dos Anjos. Liver transplantation for post-COVID-19 cholangiopathy: Report of 2 casesSurgery Case Reports 2024; 2: 100012 doi: 10.1016/j.sycrs.2024.100012
5
Ye.S. Sirchak, M.T. Maroshan, M.A. Polyak. Changes in zonulin levels and possibilities for its correction in patients with liver cirrhosis and hepatic encephalopathy after COVID-19GASTROENTEROLOGY 2024; 58(1): 31 doi: 10.22141/2308-2097.58.1.2024.584
6
Antonio Liguori, Valentin Calvez, Francesca D’Ambrosio, Angela Sciarra, Giuseppe Marrone, Marco Biolato, Antonio Grieco, Antonio Gasbarrini, Anna Alisi, Luca Miele. The bidirectional relationship between fatty liver disease and COVID-19Metabolism and Target Organ Damage 2023; 3(3) doi: 10.20517/mtod.2022.36
7
Brittany Woods, Priyal Mehta, Gowthami Sai Kogilathota Jagirdhar, Rahul Kashyap, Vikas Bansal. Management, Body Systems, and Case Studies in COVID-192024; : 523 doi: 10.1016/B978-0-443-18703-2.00008-6
8
Gianni TESTINO. SARS-CoV-2 and liver injuryPanminerva Medica 2023; 65(4) doi: 10.23736/S0031-0808.23.04926-1
9
Irit Nachtigall, Stefan Kwast, Sven Hohenstein, Sebastian König, Phi Long Dang, Johannes Leiner, Nicola Giesen, Benjamin Thomas Schleenvoigt, Marzia Bonsignore, Andreas Bollmann, Ralf Kuhlen, Fungwe Jah. Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network—The VISAGE StudyVaccines 2024; 12(6): 634 doi: 10.3390/vaccines12060634
10
Mei-Ping Chen, Di-Xuan Jiang, Jia-Xi Rang, Hai-Bo Zhuo, Zhi-Guo Zhou. Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort studyScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53862-y